Archives: Agenda
AI Customer Boards: How Firms & Corporations Are Forming AI Focus Groups to Exchange Best Practices
As AI transforms the accounting landscape, leading firms and corporations are no longer navigating this shift in isolation—they’re forming AI customer boards and focus groups to collaborate, exchange best practices, and guide responsible innovation. In this session, Jacob Sperry, VP of CX of Trullion, will explore how organizations are structuring these advisory groups to evaluate emerging technologies, align AI strategies with real client needs, and shape the future of automation in audit and finance. Drawing on insights from cross-industry leaders and early adopters, this session offers a strategic view into how collaborative governance and peer-to-peer dialogue can accelerate impact. Real-time case studies and a live demo will showcase how firms are operationalizing these principles using Trullion’s AI-powered platform.
Innovating Experience: How HLB is Rethinking Client Value
Colin Nelson, Innovation Consultant at Hype Innovation and Lesley Hornung, CMO at HLB explore how innovation and client experience are converging to shape the future of professional services. Hear how HLB is equipping its global network to deliver lasting value for clients in a fast-changing world.
SESSION 4: Creating the Firm of the Future
Networking & Refreshment Break
Conference Close
Equality, Diversity and Inclusion – Making a Difference for People, Making a Difference for Businesses
Awards & Dinner
Case study: How to successfully pick the right CRO for increased efficiency and better oncology trial results
- Identifying and creating criteria that addresses exactly what your study needs to make the selection process easier
- Strengthening relationships with CROs by communicating effectively throughout your study
- Understanding and assessing CROs capabilities tailored to your specific trial needs to avoid running into roadblocks
How to Operationally Transform Your Clinical Trial supplies with Digital Display Labels
- A key digital transformation currently in live trials is the shift from traditional paper-based relabeling to the use of digital display labels in clinical trial settings.
- The integration of digital display labels marks a significant advancement in clinical trial operations, offering enhanced efficiency and flexibility.
- As this technology evolves and gains broader adoption, it is poised to transform clinical trial management—particularly in remote monitoring, adaptive trial design, and patient engagement.
- This session will examine the limitations of traditional relabeling methods, highlight the benefits of digital display labels, and discuss their potential to reshape the future of clinical research and healthcare innovation.